Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (61-70 of 474) with videos related to

Pageof 48
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Focal therapy will become a standard option for selected men with localized prostate cancerMassimo Valerio, Mark Emberton, Hashim U Ahmed
Current Opinion in Urology|March 12, 2014
Can MRI replace serial biopsies in men on active surveillance for prostate cancer?Caroline M Moore, Neophytos Petrides, Mark Emberton
Current Opinion in Urology|March 13, 2013
The role of MRI in active surveillance of prostate cancerCaroline M Moore, Ashley Ridout, Mark Emberton
The New England Journal of Medicine|August 9, 2018
MRI-Targeted Biopsy for Prostate-Cancer DiagnosisVeeru Kasivisvanathan, Mark Emberton, Caroline M Moore
Surgical Oncology|March 10, 2009
Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancerHashim Uddin Ahmed, Caroline Moore, Mark Emberton
The Journal of Urology|July 26, 2011
Re: A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. T. Wolters, M. J. Roobol, P. J. van Leeuwen, R. C. van den Bergh, R. F. Hoedemaeker, G. J. van Leenders, F. H. Schröder and T. H. van der Kwast. J Urol 2011;185: 121-125Caroline M Moore, Laurence Klotz, Mark Emberton
Current Opinion in Urology|April 7, 2015
What tumours should we treat with focal therapy based on risk category, grade, size and location?Clement Orczyk, Mark Emberton, Hashim U Ahmed
BMJ (Clinical Research Ed.)|July 24, 2008
Endoscopic ablation: Irreversible tide of technological advancement?Hashim U Ahmed, Manit Arya, Mark Emberton
European Urology Open Science|February 24, 2022
There Is No Longer a Role for Systematic Biopsies in Prostate Cancer DiagnosisVeeru Kasivisvanathan, Mark Emberton, Caroline M Moore
The Journal of Urology|December 13, 2006
Role of alpha-blockers in type III prostatitis: a systematic review of the literatureVibhash C Mishra, John Browne, Mark Emberton
Pageof 48

Showing results (61-70 of 474) with videos related to

Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Focal therapy will become a standard option for selected men with localized prostate cancerMassimo Valerio, Mark Emberton, Hashim U Ahmed
Current Opinion in Urology|March 12, 2014
Can MRI replace serial biopsies in men on active surveillance for prostate cancer?Caroline M Moore, Neophytos Petrides, Mark Emberton
Current Opinion in Urology|March 13, 2013
The role of MRI in active surveillance of prostate cancerCaroline M Moore, Ashley Ridout, Mark Emberton
The New England Journal of Medicine|August 9, 2018
MRI-Targeted Biopsy for Prostate-Cancer DiagnosisVeeru Kasivisvanathan, Mark Emberton, Caroline M Moore
Surgical Oncology|March 10, 2009
Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancerHashim Uddin Ahmed, Caroline Moore, Mark Emberton
The Journal of Urology|July 26, 2011
Re: A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. T. Wolters, M. J. Roobol, P. J. van Leeuwen, R. C. van den Bergh, R. F. Hoedemaeker, G. J. van Leenders, F. H. Schröder and T. H. van der Kwast. J Urol 2011;185: 121-125Caroline M Moore, Laurence Klotz, Mark Emberton
Current Opinion in Urology|April 7, 2015
What tumours should we treat with focal therapy based on risk category, grade, size and location?Clement Orczyk, Mark Emberton, Hashim U Ahmed
BMJ (Clinical Research Ed.)|July 24, 2008
Endoscopic ablation: Irreversible tide of technological advancement?Hashim U Ahmed, Manit Arya, Mark Emberton
European Urology Open Science|February 24, 2022
There Is No Longer a Role for Systematic Biopsies in Prostate Cancer DiagnosisVeeru Kasivisvanathan, Mark Emberton, Caroline M Moore
The Journal of Urology|December 13, 2006
Role of alpha-blockers in type III prostatitis: a systematic review of the literatureVibhash C Mishra, John Browne, Mark Emberton
Pageof 48